Current Liabilities
Accrued Liabilities, Current
Boston Scientific Accrued Liabilities, Current decreased by 21.5% to $2.51B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $2.35B to $2.51B. Over 5 years (FY 2020 to FY 2025), Accrued Liabilities, Current shows an upward trend with a 7.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
How to read this metric
Significant fluctuations may indicate changes in operational scale, timing of bonus payouts, or shifts in expense recognition patterns.
Detailed definition
These are obligations for expenses that have been incurred but not yet invoiced or paid by the end of the reporting peri...
Peer comparison
Standard across all sectors; levels are typically proportional to the size of the workforce and operational complexity.
Metric ID:
current_liabilities_accrued_liabilities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.44B | $2.42B | $2.44B | $2.31B | $2.2B | $1.97B | $2.16B | $1.92B | $2.16B | $2.26B | $2.65B | $2.08B | $2.32B | $2.46B | $2.77B | $2.35B | $2.8B | $2.98B | $3.2B | $2.51B |
| QoQ Change | — | -1.0% | +0.7% | -5.3% | -4.7% | -10.2% | +9.4% | -11.2% | +12.8% | +4.2% | +17.3% | -21.3% | +11.4% | +6.0% | +12.7% | -15.1% | +18.8% | +6.6% | +7.4% | -21.5% |
| YoY Change | — | — | — | — | -10.0% | -18.4% | -11.3% | -16.8% | -1.5% | +14.2% | +22.5% | +8.6% | +7.2% | +9.1% | +4.8% | +13.0% | +20.6% | +21.2% | +15.4% | +6.8% |
Range$1.92B – $3.2B
CAGR+0.6%
Avg YoY Growth+5.3%
Median YoY Growth+7.9%
Accrued Liabilities, Current at Other Companies
Frequently Asked Questions
- What is Boston Scientific's accrued liabilities, current?
- Boston Scientific (BSX) reported accrued liabilities, current of $2.51B in Q1 2026.
- How has Boston Scientific's accrued liabilities, current changed year-over-year?
- Boston Scientific's accrued liabilities, current increased by 6.8% year-over-year, from $2.35B to $2.51B.
- What is the long-term trend for Boston Scientific's accrued liabilities, current?
- Over 5 years (2020 to 2025), Boston Scientific's accrued liabilities, current has grown at a 7.8% compound annual growth rate (CAGR), from $2.2B to $3.2B.
- What does accrued liabilities, current mean?
- Expenses incurred but not yet paid or invoiced.